Search

MJNA - search results

If you're not happy with the results, please do another search

0 642

HempMeds Opens Office in Mexico with Leading Advocate — CFN Media

Mexico’s Progressive Stance

Mexico has been historically opposed to marijuana legalization thanks to the United States’ War on Drugs since the 1970s. Since the 1990s, Mexican drug cartels have grown in power following the demise of the Colombian Cali and Medellin cartels. Analysts estimate that wholesale earnings from illicit drug sales range from $13.6 billion to $49.4 billion each year, which is on par with multinational tobacco companies that earn about $30 billion per year.

After many US states began taking a more progressive approach by legalizing marijuana, Mexico’s Senate passed a bill legalizing medical marijuana in December 2016. The country’s lower house in parliament followed suit by passing the bill in late-April with an overwhelming 374-7 vote. President Enrique Pena Nieto officially signed the bill into law last month, which makes medical marijuana available and legal throughout the country.

The Health Ministry will now be tasked with creating regulations around the use of medical marijuana, including the production of cannabinoid-based pharmaceuticals. In the meantime, consumers will be permitted to legally purchase cannabinoid products that contain 1% or less tetrahydrocannabinol (THC), while companies will be permitted to cultivate cannabis for medical and scientific purposes without being punished by law.

Establishing a Footprint

Medical Marijuana Inc. has been a pioneer in Mexico’s cannabinoid industry. Last year, the company secured the first import permit for RSHO-X™ — a non-psychoactive cannabidiol (CBD) hemp oil for patients suffering from severe seizures — from COFEPRIS — the country’s health authority. Many other patients have since secured import rights for the CBD oil that has shown tremendous promise in helping patients overcome severe seizures.

Earlier this year, the company began groundbreaking new studies of its RSHO-X™ in Mexico under the direction of pediatric neurologist Dr. Saul Garza Morales. The results of these studies showed a 50% or greater reduction in seizures in 33 of 39 patients, while over half of patients achieved an overall 75% reduction in seizures. But, perhaps the most striking result was the 100% seizure relief experienced by about 17% of patients in the study.

HempMeds® is expanding its presence with the opening of its first office in Monterrey, Nuevo Leon, Mexico, as demand continues to grow for RSHO-X™. The new office will be managed by medical cannabis activist and Por Grace Foundation founder Raul Elizalde and act as a hub for the sales, marketing, and distribution of RSHO-X™ to patients in Mexico. The company also aims to further its efforts to push for cannabis reform in the country. Major news outlets attended the inauguration including Forbes Mexico, HuffPost, and El Financiero among others.

Mr. Elizalde’s daughter, Grace, was the first Mexican patient to gain legal access to CBD oil, for the control of her seizures. He is recognized throughout the country for his determined efforts to expand access for more patients, and even joined President Nieto on stage in April as he announced the country’s intentions to legalize medical marijuana. His tireless dedication to the cause, and the resulting renown, should benefit the company as it grows its footprint throughout Mexico.

For more information, visit the company’s website or CannabisFN’s company profile.

0 667

Medical Marijuana, Inc. Garners National News Coverage at 4th Annual Cannabis World Congress and Business Expo in New York

Getty Images, NBC News segment highlight articles and TV interviews about Company’s CBD hemp oil; feature executives speaking on burgeoning industry

Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it garnered extensive media coverage from the 4th Annual Cannabis World Congress and Business Expo in New York, which took place on June 14-16.

Medical Marijuana, Inc.’s CEO Dr. Stuart Titus spoke to several television and radio stations about the therapeutic properties of cannabis, recent breakthroughs in medical cannabis research, and the Company’s groundbreaking Real Scientific Hemp Oil™ (RSHO™) and zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™).

“We are grateful to the press and to the International Cannabis Association for serving as an effective platform to raise awareness on the plethora of benefits of cannabidiol (CBD),” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “The CWCBE in New York was a huge success. Through the media’s coverage of the event, viewers and readers worldwide gain a much better understanding of the power of hemp oil and cannabis products, as well as the businesses that are shaping and supporting this rapidly growing industry.”

Coverage from the Expo included:

  • NBC New York: “Long Island Parents Say Pot Has Helped Sick Girl”
  • Metro: “Despite new threats from Trump administration, Cannabis Expo supports pot as a business”
  • NJTV News: “Cannabis industry holds Expo, anticipating legalization in NY, NJ”
  • Getty Images: “33 Editorial Images from the NY World Cannabis Business Expo Held in New York”

About Medical Marijuana, Inc.
We are a company of firsts ®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act.  The Company does sell and distribute hemp-based products.

CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P: 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com

0 1461
marijuana stocks

Medical Marijuana, Inc.’s CBD Oil RSHO-X™ Garners National News Headlines Across Mexico For Significantly Reducing Seizures Of Epileptic Children

SAN DIEGO, March 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Mexico garnered national news headlines across Mexico for the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of its RSHO-X™ product in treating children with severe epilepsy. HempMeds® Mexico was the first company to receive government import permits for its cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™) via the Mexican Health Department COFEPRIS.

An article from Mexico newspaper Reforma, “Ayuda cannabidiol a 84% de pacientes,” or “Cannabidiol helps 84% of patients,” explained how 84 percent of children with epilepsy treated with RSHO-X™ halved the number of seizures they suffer from, according to this first clinical study on the use of cannabis in patients with Lennox-Gastaut syndrome in Mexico.

“We are proud that our cannabidiol (CBD) hemp oil product, without THC, has enabled 17% of patients in the study to experience 100 percent relief from their seizures, the best results of any product/medication in the world regarding the reduction of seizures in Lennox-Gastaut patients,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is exciting to see such widespread news coverage of these study results by the Mexico media, as studies that prove the therapeutic benefits of CBD like Dr. Garza’s study will continue to help fuel less restrictive medical cannabis programs not only in Mexico, but across the globe. In addition, as news spreads of this revolutionary treatment for diseases such as epilepsy, more patients and families that suffer from debilitating medical conditions will receive help with medical marijuana.”

The study included 39 patients with Lennox-Gastaut syndrome, a severe form of pediatric epilepsy that typically develops before the age of 4. Of those 39 patients, who took up to 5-7mg CBD/kg progressive doses of RSHO-X™ 5000MG, 84% experienced a 50% or greater reduction in motor seizures; 53% reported better than a 75% reduction in seizures; and seven reported a complete elimination of all seizures (17%) over a four-month period, with zero reported side effects.

Results of this study are set to be published in the near future. To view the study, click here.

Other major national Mexico outlets that have reported the results of Dr. Garza’s epilepsy study with RSHO-X™ include:

Contenido

Economiahoy.mx

El Diario.mx

El Imparcial

El Mural

El Universal

Frontera.info

La Cronica

La Jornada

Radio Centro

Yahoo Mexico

Zocalo

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:
Public Relations Contact: Andrew Hard
Chief Executive Officer
CMW Media
P: 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com

0 1551

Medical Marijuana Inc.’s RSHO Approved in Brazil for Autism — CFN Media

Medical Marijuana Inc.’s RSHO™ is a natural, full-spectrum cannabidiol (CBD) oil extracted from hemp plants grown in Northern Europe. The non-GMO hemp is cultivated without the use of herbicides, pesticides, or chemical fertilizers and the resulting CBD oil passes all federal requirements for open importation into the United States, as well as strict European Union regulations governing exports.

Medical Marijuana Inc. recently announced that its HempMeds Brasil subsidiary secured approval for a prescription for RSHO to treat a patient with autism spectrum disorder. The move follows earlier approvals for the treatment of multiple sclerosis and Alzheimer’s disease, but marks the first time that Brazil’s National Health Surveillance Agency (ANVISA) has granted a prescription of the company’s RSHO™ for autism.

Mexican neurosurgeon Dr. Saul Garza also indicated that he is enrolling patients for a study on the effects of CBD on autism. Earlier, Dr. Garza concluded a study on Lennox-Gastaut epilepsy in Mexico with favorable results for the botanical CBD version that is allowed into Mexico (RSHO-X). These results will be published in the near future and presented at the International Epilepsy Congress in Barcelona, Spain on September 2-6, 2017.

Please follow the link to read the full article: http://www.cannabisfn.com/medical-marijuana-inc-s-rsho-approved-brazil-autism/

Learn how to become a CFN Media featured company, brand or entrepreneur:http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit http://www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

0 767

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc., Discusses Recent News and Events in a New Audio Interview at SmallCapVoice.com

Medical Marijuana, Inc. (OTC Pink:MJNA) and SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc.,  the first-ever publicly traded cannabis company in the United States, is now available. The interview can be heard at http://bit.ly/2mqr7ny.

Stuart W. Titus, PhD, the CEO of Medical Marijuana, Inc., called in to SmallCapVoice.com to provide the listening audience with his personal insights into the Company’s recent news and the feedback from his recent trip to speak to investors at The Money Show Orlando about cannabis industry trends and investment opportunities and how biotech companies are producing cannabinoid-based pharmaceuticals that have the potential to improve the daily life of millions across the globe.

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

0 1602

Medical Marijuna, Inc. Investment AXIM(R) Biotech Receives Positive PK Data Results for CanChew Plus(R) CBD Gum

Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials with patients suffering from irritable bowel syndrome (IBS).

The single dose study on 10 mg of cannabidiol (CBD) and 30 mg of CBD determined the concentration of CBD in the blood after chewing one CanChew Plus® Gum for thirty minutes in healthy volunteers. The 30 mg dosage showed excellent results and this data will be used to determine the optimal concentration in the IBS patient trial.

“Yet again, AXIM continues to impress the industry with this study on its proprietary delivery method for cannabinoids and ground-breaking research in the field,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “With this data, AXIM will be able to formulate the optimal dosage for its clinical trial products to render the most positive results for their patients.”

“AXIM is among just a few companies conducting clinical research on the benefits of cannabinoids. Their research will be the catalyst for change in many sectors of the pharmaceutical industry as we believe that cannabinoid therapeutics has the potential to restructure certain aspects of how medicine will be practiced. We applaud the AXIM team and support continued efforts on this front,” added Dr. Titus.

There are very few effective treatments for IBS, which effects between 25 and 45 million people in the United States and around 10-15% of the world population. AXIM intends to bring a pharmaceutical solution to the IBS market, which is estimated to be worth $1.5 billion by 2023.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

About AXIM®

AXIM® Biotechnologies, Inc. (AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew®, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. We prioritize the well-being of our customers while embracing a solid fiscal strategy. Medical Marijuana, Inc. is a major investor in AXIM. For more information, visit www.AXIMBiotech.com.

About CanChew® and CanChew Plus®

CanChew® is a unique hemp-derived CBD functional chewing gum that is distinctly different than any other brands of gum on the market. Features listed on the CanChew® website include:

  • Non-habit forming
  • No prescription needed
  • Available in all 50 states
  • Great-tasting mint gum has no artificial sweeteners or preservatives
  • Non-GMO, gluten free, vegan and kosher

CanChew Plus® is a vastly improved delivery system than the alpha version of CanChew® Gum. It is produced by a leading European functional gum manufacturer.

Featured in Healthy Living Magazine, CanChew® was also recognized by the HealthyLivinG Foundation and honored with its Triple Leaf Award.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

0 1825

Medical Marijuana, Inc. Releases In-Depth Video Series Featuring New Executive Team and Lives Strengthened by Company’s Products

As part of an outreach campaign, the company has decided to highlight various individuals that have been affected by the company’s now ever-expanding presence around the globe. The video marks a milestone in the company’s consistent rise as one of the foremost leaders in the medical cannabis and hemp industry.

The series can be accessed for viewing on www.medicalmarijuanainc.com. In addition to personal stories of success, the video brings viewers on a journey that follows the rise of the company, from its beginnings as a startup to its standing as one of the leading innovators in the cannabis and hemp industry.

“In the case of our new video series, seeing really is believing,” said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. “We are honored to bring our story of hope to the world. It is one thing to hear about the transformative effects of our products, or to read about it in research studies. But starting today, you can now see the real-life impact our products offer to countless lives around the world.”

Dr. Titus added, “There are many who suffer in silence and whose calls for help go unanswered. However, because of the strides made by our company, I am pleased to say that we are beginning to answer those calls. This video is our chance to tell the world that we hear your pain. I am confident that with our continued strides in the cannabis and hemp industry, we will make the world a better place.”

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

1 2027

Medical Marijuana, Inc. Garners National News Coverage on Fox, ABC, CW on Historic Night as Marijuana Reform Passes Across U.S.

Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus was interviewed on CW 6 News San Diego and National and local ABC affiliates, speaking about the social and medical benefits of legalizing both recreational and medical marijuana.

“The sweeping passage of cannabis reform across the country is a major win for the cannabis industry,” said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. “The voters have spoken and they’ve made it clear that they are ready for cannabis reform, moving forward the newest multibillion-dollar industry in the U.S.”

In a historic night on U.S. election day Nov. 8, voters in California, Nevada, Maine and Massachusetts passed recreational use of marijuana in their respective states, while Florida, North Dakota, Montana, and Arkansas approved medical marijuana initiatives. The combined estimated legal marijuana markets for these states is a billion-dollar market this year, with the total market surpassing well over $40 billion by 2020.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

0 1093

Medical Marijuana Inc.’s First-Ever Import Permit for RSHO in Paraguay Covered by Associated Press and Nation’s Top TV News Channel

Massive Coverage Across Latin America After Government of Paraguay Grants First-Ever Import Permit for Real Scientific Hemp Oil(TM) (RSHO(TM))

Medical Marijuana, Inc. (OTC PINK: MJNA)announced today that the Associated Press and Paraguay’s top television news channel Telefuturo covered the historic news of the government of Paraguay granting its first-ever import permit forReal Scientific Hemp Oil™ (RSHO™) as a prescription medication for refractory epilepsy.

The Associated Press article titled “Paraguay importara aceite de marihuana de Estados Unidos (Parguay imports hemp oil from the United States),” features comments from a spokesman for the Paraguay Government’s National Anti-Drug Secretariat about the country’s decision to allow RSHO™ into the country. The Telefuturo broadcast is titled: “Autorizan importación de aceite de cannabis para uso medicina (Hemp oil authorized for import for medical use.)”

Dr. Stuart Titus, CEO of Medical Marijuana, Inc., said, “We’re humbled and grateful that top media outlets continue to cover these historic events of countries authorizing import permits forRSHO™. It’s exciting to hear about residents who are experiencing the real benefits of cannabidiol (CBD) oil for the very first time. We want everyone around the world to have access to RSHO™, and we gratefully applaud the government of Paraguay for acting so swiftly on behalf of the health and welfare of their people.”

In May 2016, the Paraguay government authorized RSHO™ for import into the country as a prescription medication for refractory epilepsy — making it the third country in Latin America afterBrazil and Mexico, along with Puerto Rico in the Caribbean — to approve Medical Marijuana Inc.’s CBD hemp oil for multiple medical indications. Currently, Medical Marijuana, Inc.’sRSHO™ products are shipping to more than 40 countries around the world.

Other coverage in both Paraguay and Brazil of Medical Marijuana, Inc. and the historic first-ever import permit for RSHO™ into Paraguay this week has included:

Paraguay.com: http://www.paraguay.com/nacionales/paraguay-aprueba-medicina-con-base-en-canabbis-145324

Asuncion Digital: http://asunciondigital.com/paraguay-aprueba-medicina-con-base-en-cannabis/

Ganar Salud: http://amigosdeganarsalud.com/2016/06/01/paraguay-aprueba-uso-de-cannabis/

Salad Hoy: http://saludhoy.paraguay.com/paraguay-aprueba-medicina-con-base-en-cannabis-145324.html

Radio Marandu: http://www.radiomarandu.com.py/index.php?option=com_content&view=article&id=20500:paraguay-aprueba-medicina-con-base-en-cannabis&catid=54:nacionales

Terra Noticias: https://noticias.terra.com.co/mundo/paraguay-importara-aceite-de-marihuana-de-estados-unidos,6851d7c814fb5fc257267723cf6374a6h2gfw2vq.html

Dementesx: http://www.dementesx.com/rsho-medicina-cannabis-tratamiento-epilepsia-paraguay/

Notici Actual: http://www.noticiactual.com/actualidad/paraguay-importara-aceite-de-marihuana-de-estados-unidos.html

Panorama.com:http://m.panorama.com.ve/curiosidades/Paraguay-importara-aceite-de-marihuana-de-Estados-Unidos-20160603-0037.html

Universal FM Radio: http://www.universalfmradio.com/blog/paraguay-importara-aceite-de-marihuana-de-estados-unidos/#.V1G3b_krLcs

Noticias Colombianas: http://www.noticiascolombianas.com.co/index.php/272804/paraguay-importara-aceite-de-marihuana-de-estados-unidos/

tn8TV: http://www.tn8.tv/sucesos/311607-paraguay-importara-aceite-marihuana-estados-unidos/

Noticias Sin: http://www.noticiassin.com/2016/06/paraguay-importara-aceite-de-marihuana-de-estados-unidos/

I24 Web: http://i24web.com/paraguay-importara-aceite-de-marihuana-desde-estados-unidos/

El Universal: http://www.eluniversal.com.co/mundo/paraguay-importara-aceite-de-marihuana-de-estados-unidos-227595

Cb24 TV: http://cb24.tv/paraguay-importara-aceite-de-marihuana-de-estados-unidos/

Centro Tampa: http://www.centrotampa.com/ce/list/estados-unidos/paraguay-importar-aceite-de-marihuana-de-estados-unidos-ap_spanish_-_united_statesecf11a4c01ee42b2bad5eb8ed4d321bb/

Vivelo Hoy: http://www.vivelohoy.com/ultimas-noticias/8637120/paraguay-importara-aceite-de-marihuana-de-estados-unidos

CDN: http://www.cdn.com.do/noticias/2016/06/03/paraguay-importara-aceite-de-marihuana-de-estados-unidos/

20Minutos.com: http://www.20minutos.com/noticia/49520/0/paraguay-importara-aceite-de-marihuana-de-estados-unidos/

OA.com: http://www.oaoa.com/article_209c0221-bf51-5212-bbe3-2ae833d80ec7.html

Tities.ws: http://titles.ws/colombia/co2016060327471899288499.php

Parguay.com: http://www.paraguay.com/nacionales/aceite-de-cannabis-se-utilizara-bajo-la-figura-del-uso-compasivo-145472

GrowLandia: http://growlandia.com/marihuana/paraguay-aprueba-nuevos-medicamentos-con-base-de-cannabis/

Etcetera:http://www.etcetera.com.mx/articulo/Aprueba+Paraguay+importaci%C3%B3n+de+aceite+de+marihuana+para+paciente+con+epilepsia/46229

Diario al Instante: http://diarioalinstante.com/paraguay-importara-aceite-marihuana-tratamiento-paciente-epilepsia/2016/06/03/

About Medical Marijuana Inc. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

The Company is committed to consistently providing the highest-quality CBD hemp oil productson the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Contact:
Contact information

Public Relations
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829-0070
andrew.hard@cmwmedia.com
www.cmwmedia.com

Corporate Business
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: info@equinet.us
www.equinet.us

0 926

A New Audio Interview with Dr. Stuart Titus, President and Chief Executive Officer of Medical Marijuana, Inc., is now at SmallCapVoice.com

Medical Marijuana, Inc. (OTC Pink:MJNA) and SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc., a leading industrial hemp industry innovator, is now available. The interview can be heard at http://smallcapvoice.com/blog/5-16-16-smallcapvoice-interview-with-medical-marijuana-inc-mjna

Stuart W. Titus, PhD, President and CEO of Medical Marijuana, Inc. called in to SmallCapVoice.com to provide the listening audience with his personal insights into the Company’s recent news regarding how the Brazilian government has approved its hemp cannabidiol (CBD) oil product, Real Scientific Hemp Oil™ (RSHO™) fromHempMeds Brasil™, for a fourth indication for import as a prescription medication for the treatment of cancer. In addition, Dr. Titus discussed that the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product is the first-ever cannabis product (high concentration natural botanical hemp-based cannabidiol (CBD) without THC) approved by federal authorities for import into Mexico, into what projects to be a “$10-12 billion” future cannabis market.

Dr. Titus states, “The U.S. is slowly moving forward with the legalization of medical cannabis and while we have great hopes for November’s elections — we see many Latin American countries moving forward in a swift manner toward the acceptance of non-psychoactive cannabinoids. Previously the acceptance of any cannabis-based product would have been unheard of in these nations — but with our education combined with different systems of medical care, that is now rapidly changing. MJNA’s brands RSHO and RSHO-X are welcome in two of Latin America’s biggest countries and Puerto Rico has 12 registrations with our products. We look forward to reporting on further developments of this trend in the future.”

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visithttp://smallcapvoice.com/blog/smallcapvoice-about-our-small-cap-otc-investor-relations-company/

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER 
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE 
Medical Marijuana Inc. and HempMeds® do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value.  For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements